Randomized Phase IIA Trial of Gemcitabine Compared With Bleomycin Plus Vincristine for Treatment of Kaposi's Sarcoma in Patients on Combination Antiretroviral Therapy in Western Kenya.

Busakhala, Naftali W; Waako, Paul J; Strother, Matthew Robert; Keter, Alfred Kipyegon; Kigen, Gabriel Kimutai; Asirwa, Fredrick Chite; Loehrer, Patrick J

Busakhala, Naftali W; Waako, Paul J; Strother, Matthew Robert; Keter, Alfred Kipyegon; Kigen, Gabriel Kimutai; Asirwa, Fredrick Chite; Loehrer, Patrick J.

Afiliação

Busakhala NW; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Waako PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Strother MR; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Keter AK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Kigen GK; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Asirwa FC; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni
Loehrer PJ; Naftali W. Busakhala, Gabriel Kimutai Kigen, Moi University School of Medicine; Alfred Kipyegon Keter, and Patrick J. Loehrer Sr, AMPATH Statistics, Eldoret, Kenya; Paul J. Waako, Makerere College of Health Sciences, Kampala, Uganda; Matthew Robert Strother, Canterbury District Health Board, and Uni

J Glob Oncol ; 4: 1-9, 2018 09.

Article em En | MEDLINE | ID: mdl-30241150

Assuntos

Antirretrovirais/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Bleomicina/uso terapêutico; Desoxicitidina/análogos & derivados; Vincristina/uso terapêutico; Adulto; Idoso; Antirretrovirais/farmacologia; Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia; Bleomicina/farmacologia; Desoxicitidina/farmacologia; Desoxicitidina/uso terapêutico; Humanos; Quênia; Pessoa de Meia-Idade; Projetos Piloto; Sarcoma de Kaposi; Vincristina/farmacologia; Adulto Jovem; Gencitabina

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vincristina / Bleomicina / Protocolos de Quimioterapia Combinada Antineoplásica / Antirretrovirais / Desoxicitidina Tipo de estudo: Clinical_trials Limite: Adult / Aged / Humans / Middle aged País como assunto: Africa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google